At the time of writing, Zura Bio Ltd [ZURA] stock is trading at $1.96, up 51.94%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ZURA shares have gain 41.01% over the last week, with a monthly amount glided 63.33%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Zura Bio Ltd [NASDAQ: ZURA] stock has seen the most recent analyst activity on November 04, 2024, when Leerink Partners initiated its Outperform rating and assigned the stock a price target of $15. Previously, H.C. Wainwright started tracking the stock with Neutral rating on September 05, 2024, and set its price target to $5. On May 03, 2024, Piper Sandler initiated with a Overweight rating and assigned a price target of $26 on the stock. Ladenburg Thalmann started tracking the stock assigning a Buy rating and suggested a price target of $10 on October 10, 2023. Oppenheimer initiated its recommendation with a Outperform and recommended $17 as its price target on August 25, 2023. Guggenheim started tracking with a Buy rating for this stock on June 22, 2023, and assigned it a price target of $20. In a note dated June 14, 2023, Chardan Capital Markets initiated an Buy rating and provided a target price of $14 on this stock.
For the past year, the stock price of Zura Bio Ltd fluctuated between $0.97 and $5.07. Currently, Wall Street analysts expect the stock to reach $3 within the next 12 months. Zura Bio Ltd [NASDAQ: ZURA] shares were valued at $1.96 at the most recent close of the market. An investor can expect a potential return of 53.06% based on the average ZURA price forecast.
Analyzing the ZURA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.37, Equity is -0.43 and Total Capital is -0.44.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Zura Bio Ltd [NASDAQ:ZURA] has a current ratio of 8.14. In addition, the Quick Ratio stands at 8.14 and the Cash Ratio stands at 8.09.
Transactions by insiders
Recent insider trading involved Thiara Parvinder, Director, that happened on Nov 25 ’24 when 1.0 million shares were sold. Director, Thiara Parvinder completed a deal on Sep 11 ’24 to sell 3.8 million shares. Meanwhile, Director Sidhu Someit sold 51728.0 shares on Sep 04 ’24.
